These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36219353)

  • 1. Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.
    Yang X; Wu P; Wang Z; Su X; Wu Z; Ma X; Wu F; Zhang D
    Mol Cell Biochem; 2023 May; 478(5):1083-1097. PubMed ID: 36219353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 3. Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis.
    Yang X; Qu Y; Zhang J
    Arch Med Res; 2022 Jan; 53(1):9-19. PubMed ID: 34362591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A.
    Xie R; Liu C; Liu L; Lu X; Tang G
    Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):452-462. PubMed ID: 35607960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis.
    Li QY; Chen L; Hu N; Zhao H
    Biomed Pharmacother; 2018 Jul; 103():1727-1732. PubMed ID: 29864963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
    Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
    Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
    Zhang T; Yu S; Zhao S
    Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
    Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D
    Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
    Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
    Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway.
    Fang J; Yang J; Chen H; Sun W; Xiang L; Feng J
    Hum Cell; 2022 Sep; 35(5):1521-1534. PubMed ID: 35816228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
    Liu HT; Ma RR; Lv BB; Zhang H; Shi DB; Guo XY; Zhang GH; Gao P
    Br J Cancer; 2020 Jun; 122(12):1825-1836. PubMed ID: 32336754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.
    Hu C; Li S; Fu X; Zhao X; Peng J
    Cytokine; 2023 Feb; 162():156105. PubMed ID: 36527891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
    Geng S; Tu S; Fu W; Wang J; Bai Z
    Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.